VSBC — Vitaspring Biomedical Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapNeutral

Annual balance sheet for Vitaspring Biomedical, fiscal year end - January 31st, USD millions except per share, conversion factor applied.

	C2022 January 31st	2023 January 31st	2024 January 31st	2025 January 31st	2026 January 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	0.107	0.03	0	0	0.002
Net Total Accounts Receivable
Net Total Receivables	2.95	0.38	0	0	—
Prepaid Expenses
Total Other Current Assets
Total Current Assets	3.06	0.437	0.024	0	0.011
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.525	0.305	0.114	0.014	0.004
Other Long Term Assets
Total Assets	3.6	0.766	0.137	0.014	0.015
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	1.74	3.07	3.49	4.03	4.45
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	2.03	3.16	3.49	4.03	4.45
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	1.58	-2.4	-3.35	-4.02	-4.43
Total Liabilities & Shareholders' Equity	3.6	0.766	0.137	0.014	0.015
Total Common Shares Outstanding